Quanta Pharma Retatrutide 50mg
Original price was: $250.00.$220.00Current price is: $220.00.
Retatrutide 50mg
Triple Agonist
Lyophilized Vial
10ml
FREE SHIPPING
On orders over £200
✓
Research Grade
UK Fast Dispatch
Dual Lab Verified
Description
IN SHORT
Quanta Pharma Retatrutide 50mg is a synthetic triple agonist peptide studied for activity at the GLP-1, GIP and glucagon receptor pathways. This research compound is supplied as a lyophilized 50mg vial in the new 10ml vial format and has been independently tested by two laboratories.
Independently Lab Verified
Independent testing across two laboratories.
Analiza Białek
54.25mg Actual Content
99% Purity
Sample: Sealed lyophilized vial
Order: 100016870
Method: HPLC (BioBasic 8 Thermo Scientific)
Verification Key: F5J12Z9A
Tested: 10 August 2026
Janoshik
62.40mg Actual Content
99.84% Purity
Method: Blind Screen
Tested: September 2025
Verification Key: RX4AKSZF838E
Verify Janoshik results at
janoshik.com/verify
Quanta Pharma Retatrutide 50mg is a synthetic peptide compound studied for activity at three receptor pathways: GLP-1, GIP and glucagon. This Retatrutide 50mg peptide is supplied as a lyophilized vial from Quanta Pharma for controlled laboratory research.
The product is supplied in a 10ml vial format. Independent laboratory testing information is available from both Analiza Białek and Janoshik, providing batch-specific information on purity and actual content.
Retatrutide 50mg Specifications
Retatrutide
Triple Agonist
50mg/vial
99%+
Lyophilized
10ml
Retatrutide 50mg by Quanta Pharma
Lyophilized Retatrutide supplied in a 50mg vial using the new 10ml vial format. Independent laboratory testing information is available from Analiza Białek and Janoshik for batch verification and product reference.
Retatrutide Research Benefits
- Triple receptor activity – Retatrutide is studied for activity at GLP-1, GIP and glucagon receptor pathways.
- GLP-1 receptor research – Investigated for activity involving the glucagon-like peptide-1 receptor pathway.
- GIP receptor research – Studied alongside GLP-1 and glucagon pathways to investigate combined receptor signalling.
- Glucagon receptor research – Investigated for its role in metabolic and energy-related signalling pathways.
- Metabolic research – Studied in controlled laboratory research involving metabolic regulation and related physiological pathways.
- Dual laboratory testing – Independent testing information is available from both Analiza Białek and Janoshik.
How Retatrutide Works
Retatrutide is a synthetic peptide compound studied as an agonist at three receptor pathways: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide) and the glucagon receptor.
This triple-receptor profile makes Retatrutide relevant to laboratory research examining interactions between GLP-1, GIP and glucagon signalling pathways.
Research involving Retatrutide can examine receptor activity, intracellular signalling, metabolic pathways and related biological processes under controlled laboratory conditions.
Retatrutide 50mg vs Tirzepatide vs Semaglutide
Semaglutide is primarily studied for activity at the GLP-1 receptor, while Tirzepatide is studied for activity at both GLP-1 and GIP receptors. Retatrutide is investigated for activity across GLP-1, GIP and glucagon receptor pathways.
This difference in receptor activity makes Retatrutide 50mg relevant to research examining triple-receptor signalling and related metabolic pathways.
Retatrutide 50mg UK
Retatrutide 50mg is supplied as a lyophilized research compound in a 50mg vial. The product is now supplied in a 10ml vial format.
For researchers looking for Retatrutide 50mg in the UK, this product page provides information about the compound, vial format, stated specifications and available independent laboratory testing.
For Laboratory Research Use Only
NOT FOR HUMAN OR VETERINARY DIAGNOSTIC OR THERAPEUTIC USE.
This material is supplied exclusively for laboratory research purposes. It is not intended for human consumption, self-administration, diagnosis, treatment or prevention of disease.
Researchers should consult the applicable product documentation, safety information and local regulations before handling or working with this material.
Related products
-
Sale!
Quanta Pharma Tirzepatide 60mg
Original price was: $220.00.$185.00Current price is: $185.00. -
Sale!
Quanta Pharma Tirzepatide 30mg
Original price was: $125.00.$105.00Current price is: $105.00. -
Sale!
Quanta Pharma Retatrutide 30mg
Original price was: $175.00.$155.00Current price is: $155.00.
Reviews
There are no reviews yet.